RTS,S/AS02D | Hepatitis B Vaccine | Point estimate of VE adjusted for covariates | |||||||
---|---|---|---|---|---|---|---|---|---|
Subjects (N) | No. of events | PYAR | Subjects (N) | No. of events | PYAR | (%) | 95% CI | Â | P value |
Primary Case Definition: multiple episodes | |||||||||
Months 2.5 – 14 | |||||||||
146 | 18 | 124.48 | 151 | 30 | 127.91 | 50.7 | −6.5 | 77.1 | 0.072 |
Months 2.5 – 20 | |||||||||
146 | 42 | 193.41 | 151 | 51 | 198.29 | 26.7 | −33.1 | 59.6 | 0.307 |
Primary Case Definition: first or only | |||||||||
Months 2.5 – 14 | |||||||||
146 | 13 | 121.04 | 151 | 24 | 121.34 | 53.6 | 8.6 | 76.4 | 0.026 |
Months 2.5 – 20 | |||||||||
146 | 26 | 181.92 | 151 | 34 | 178.56 | 34.9 | −8.8 | 61.1 | 0.101 |